Pinned Repositories
Modeling_Cytokine_Release
How to cite: Van De Vyver, A. J., Marrer-Berger, E., Wang, K., Lehr, T., & Walz, A.-C. (2021). Cytokine release syndrome by T-cell-redirecting therapies: can we predict and modulate patient risk? Clinical Cancer Research
PBPK_model_antibody_brain_uptake
PKPD_modeling_epigenetic_modifiers
Walz et al. 2022. Leveraging modeling and simulation to optimize the therapeutic window for epigenetic modifier drugs
time-independent_analysis_in_vitro
How to cite: Van De Vyver, A.J., Eigenmann, M.J., Ovacik, M., Pöhl, C., Herter, S., Weinzierl, T., Fauti, T., Klein, C., Lehr, T., Bacac, M., Walz, A.-C. (2021). A novel approach for quantifying the pharmacological activity of T cell engagers utilizing in vitro time course experiments and streamlined data analysis. AAPS
PKPD-coder's Repositories
PKPD-coder/Modeling_Cytokine_Release
How to cite: Van De Vyver, A. J., Marrer-Berger, E., Wang, K., Lehr, T., & Walz, A.-C. (2021). Cytokine release syndrome by T-cell-redirecting therapies: can we predict and modulate patient risk? Clinical Cancer Research
PKPD-coder/PBPK_model_antibody_brain_uptake
PKPD-coder/PKPD_modeling_epigenetic_modifiers
Walz et al. 2022. Leveraging modeling and simulation to optimize the therapeutic window for epigenetic modifier drugs
PKPD-coder/time-independent_analysis_in_vitro
How to cite: Van De Vyver, A.J., Eigenmann, M.J., Ovacik, M., Pöhl, C., Herter, S., Weinzierl, T., Fauti, T., Klein, C., Lehr, T., Bacac, M., Walz, A.-C. (2021). A novel approach for quantifying the pharmacological activity of T cell engagers utilizing in vitro time course experiments and streamlined data analysis. AAPS